arrow
V

Vidal Essebag

mcgill university health center
H指数:49
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation

房颤导管消融成功后的抗凝治疗

2025-11-014
PRE
Catheter Ablation versus Sotalol or Amiodarone for Ventricular Tachycardia: A Substudy of the VANISH2 Trial

导管消融与索他洛尔或胺碘酮治疗室性心动过速的比较:VANISH2试验的亚组研究

JACC
IF0
2025-10-110
OAAI
Atrial Fibrillation Progression in Patients with Device-Detected Subclinical Atrial Fibrillation: Insights from the ARTESiA Trial

设备检测到的亚临床心房颤动患者中心房颤动进展:ARTESiA试验的见解

2025-07-090
PRE
Adaptive versus conventional cardiac resynchronisation therapy in patients with heart failure (AdaptResponse): a global, prospective, randomised controlled trial

适应性与常规心脏再同步治疗在心力衰竭患者中的应用 (AdaptResponse): 一项全球性、前瞻性、随机对照试验

LANCET
IF88.5
2023-09-0120
PRE
Association of the Timing and Extent of Cardiac Implantable Electronic Device Infections With Mortality
2023-05-017
OA
Standard vs Augmented Ablation of Paroxysmal Atrial Fibrillation for Reduction of Atrial Fibrillation Recurrence The AWARE Randomized Clinical Trial
2023-05-016
OA
Characterization of arrhythmia substrate to ablate persistent atrial fibrillation (COAST-AF): Randomized controlled trial design and rationale
2022-12-012
PRE
Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients With Heart Failure and Atrial Fibrillation: Results from the RAFT-AF trial
2022-06-0787
OA
OCEAN trial update
2022-06-011
PRE
Augmented wide area circumferential catheter ablation for reduction of atrial fibrillation recurrence (AWARE) trial: Design and rationale
2022-06-012
PRE